We are live on
!
Find out more
PAM
Panagora Asset Management Portfolio holdings
AUM
$32.6B
1-Year Est. Return
52.29%
This Fund
S&P 500
This Quarter
Est. Return
+10.18%
1 Year Est. Return
+52.29%
3 Year Est. Return
+171.1%
5 Year Est. Return
+242.78%
10 Year Est. Return
+962.16%
AUM
$17.8B
AUM Growth
+$911M
(+5.4%)
Cap. Flow
-$368M
Cap. Flow
% of AUM
-2.07%
Top 10 Holdings %
Top 10 Hldgs %
23.09%
Holding
3,154
New
338
Increased
1,006
Reduced
790
Closed
311
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$69.1M |
| 2 |
Citigroup
C
|
+$66.4M |
| 3 |
3M
MMM
|
+$62.2M |
| 4 |
Home Depot
HD
|
+$50.7M |
| 5 |
Agilent Technologies
A
|
+$49.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walmart Inc
WMT
|
+$90.6M |
| 2 |
Merck
MRK
|
+$74.3M |
| 3 |
Allstate
ALL
|
+$60.1M |
| 4 |
Salesforce
CRM
|
+$60M |
| 5 |
Northrop Grumman
NOC
|
+$54.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.66% |
| 2 | Financials | 14.5% |
| 3 | Healthcare | 12.57% |
| 4 | Consumer Discretionary | 12.57% |
| 5 | Industrials | 8.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
426
CorVel
CRVL
$3.19B
| $5.88M | 0.03% |
172,083
-5,577
| -3% | -$194K |
|
427
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$16.6B
| $5.83M | 0.03% |
66,854
+805
| +1% | +$70K |
|
428
Rockwell Automation
ROK
$49B
| $5.82M | 0.03% |
21,908
+11,809
| +117% | +$3.01M |
|
|
NXGN
429
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $5.77M | 0.03% |
318,988
+42,852
| +16% | +$846K |
|
430
Lam Research
LRCX
$390B
| $5.75M | 0.03% |
96,660
-7,670
| -7% | -$418K |
|
431
Chipotle Mexican Grill
CMG
$41.5B
| $5.74M | 0.03% |
202,100
+142,750
| +241% | +$4.13M |
|
|
SNBR
432
DELISTED
Sleep Number
SNBR
| $5.74M | 0.03% |
39,987
-3,544
| -8% | -$425K |
|
|
MANT
433
DELISTED
Mantech International Corp
MANT
| $5.73M | 0.03% |
65,923
+63,723
| +2,897% | +$5.55M |
|
434
TechTarget
TTGT
$278M
| $5.71M | 0.03% |
82,182
-42,462
| -34% | -$3.3M |
|
435
Veracyte
VCYT
$3.8B
| $5.71M | 0.03% |
106,153
+85,868
| +423% | +$4.95M |
|
436
Booz Allen Hamilton
BAH
$9.15B
| $5.66M | 0.03% |
70,275
+6,181
| +10% | +$519K |
|
437
General Mills
GIS
$19.7B
| $5.65M | 0.03% |
92,205
-74,899
| -45% | -$4.32M |
|
438
Plexus
PLXS
$7.23B
| $5.62M | 0.03% |
61,141
-221
| -0.4% | -$18.7K |
|
|
ARNA
439
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $5.59M | 0.03% |
80,548
-4,768
| -6% | -$367K |
|
|
DOCU
440
DocuSign
DOCU
$11.5B
| $5.51M | 0.03% |
27,218
-9,255
| -25% | -$2.15M |
|
441
FIVE9
FIVN
$2.54B
| $5.51M | 0.03% |
35,227
-491
| -1% | -$83.9K |
|
|
GRMN
442
Garmin
GRMN
$60B
| $5.48M | 0.03% |
41,548
+2,956
| +8% | +$368K |
|
443
AngioDynamics
ANGO
$649M
| $5.45M | 0.03% |
232,730
-6,920
| -3% | -$140K |
|
444
Equinix
EQIX
$103B
| $5.43M | 0.03% |
7,985
-13,322
| -63% | -$9.14M |
|
445
Highwoods Properties
HIW
$3.47B
| $5.41M | 0.03% |
126,047
+97,632
| +344% | +$3.98M |
|
446
Vistra
VST
$47.4B
| $5.4M | 0.03% |
305,618
-83,825
| -22% | -$1.67M |
|
447
Arcus Biosciences
RCUS
$3.64B
| $5.4M | 0.03% |
192,150
+47,363
| +33% | +$1.65M |
|
448
Aon
AON
$76B
| $5.39M | 0.03% |
23,409
-16,729
| -42% | -$3.68M |
|
449
Darden Restaurants
DRI
$24.4B
| $5.32M | 0.03% |
37,439
+27,407
| +273% | +$3.61M |
|
450
Cencora
COR
$61.2B
| $5.31M | 0.03% |
44,970
+32,820
| +270% | +$3.55M |
|
Similar funds
GAM
PPF
Panagora Asset Management's Q1 2021 Portfolio in Review
As of Q1 2021, Panagora Asset Management held 3,154 positions worth $17.8B, up 5.4% from $16.9B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Panagora Asset Management's Q1 2021 filing shows 338 new, 1,006 increased, 790 reduced and 311 closed positions. Its largest new stake was Fate Therapeutics: 162,596 shares worth $13.4M. The largest sale was Walmart Inc, an estimated $90.6M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Financials and Healthcare.
- Panagora Asset Management's largest Q1 2021 buy was Fate Therapeutics: 162,596 shares worth $13.4M.
- Panagora Asset Management added most to AbbVie in Q1 2021, an estimated $69.1M increase.
- Panagora Asset Management's biggest Q1 2021 reduction was Walmart Inc, cutting an estimated $90.6M.
- Panagora Asset Management fully exited iShares MSCI Taiwan ETF in Q1 2021, selling an estimated $9.74M.
- Panagora Asset Management's ten largest holdings make up 23% of its $17.8B portfolio in Q1 2021.
- Panagora Asset Management opened 338 new positions and closed 311 in Q1 2021.
- Panagora Asset Management's portfolio value rose 5.4% quarter-over-quarter to $17.8B.
Based on Panagora Asset Management's 13F filing for Q1 2021, filed 12 May 2021.